• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS
  • Email newsletter

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Caroline Richards on +44 (0)1959 563311 or email us.

 

Transmission Raman method gains regulatory approval for content uniformity batch release test

Posted on: 25 November 2014 | Source: Cobalt Light Systems

Cobalt Light Systems is pleased to announce that a major pharmaceutical company has gained regulatory approval to release products using Cobalt’s TRS100 instrument instead of by HPLC...

Video: bioMérieux’s Jennifer Garrett interviewed at PDA conference on Pharmaceutical Microbiology

Posted on: 25 November 2014 | Source: Graeme Cathie, European Pharmaceutical Review

Graeme Cathie speaks with Jennifer Garrett, Regional Business Manager, BioPharma, bioMérieux at the PDA conference on Pharmaceutical Microbiology...

European Commission approves Rezolsta, a new once-daily, fixed-dose HIV therapy combining darunavir and cobicistat

Posted on: 25 November 2014 | Source: Janssen

Janssen-Cilag International NV announced that the European Commission (EC) has approved the use of REZOLSTA® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years or older...

Promethera Biosciences raises €25.33 million ($31.4 million) in Series C financial round

Posted on: 25 November 2014 | Source: Promethera Biosciences

Promethera Biosciences, a Belgian biotechnology company developing Promethera® HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital...

A new survey by Braun reveals how the South East’s blood is boiling over

Posted on: 25 November 2014 | Source: Braun

Nationwide consumer survey sponsored by Braun discovers that regular blood pressure measurement must become a higher priority...

Roche to increase payroll in Switzerland by 1.4 percent

Posted on: 25 November 2014 | Source: Roche

Roche is increasing the payroll for its workforce of over 13,000 in Switzerland by 1.4 percent with effect from 1 April 2015...

Medical device market ripe for investments in Eastern Europe

Posted on: 25 November 2014 | Source: Frost & Sullivan

Frost & Sullivan profiles key medical device manufacturers in the region, where the market is expected to grow at a CAGR of 3.1 percent between 2014 and 2018...

Bioquell publishes case studies on the efficacy of its wound treatment solution

Posted on: 24 November 2014 | Source: Bioquell

The Bioquell wound treatment system, BioxyQuell, has been tested at a wound care clinic in Hampshire with patients suffering from long term chronic venous leg ulceration. The results, presented in two case studies, show how aqueous oxygen peroxide (AOP) applied using the BioxyQuell system reduced odours and pain as well as improved wound healing...

Lucideon launches composites information service

Posted on: 24 November 2014 | Source: Lucideon

Lucideon, the international provider of materials development, testing and assurance, has launched a new Composites Information Service.

Online Discussion: Practical Application of RMM in Pharmaceutical Manufacturing

Posted on: 24 November 2014 | Source: Dr. Yongqiang Zhang, Senior Scientist, BD Diagnostics

This online discussion will demonstrate how a rapid method can provide a solution to a common microbiological testing problem for pharmaceutical manufacturers – process water microbiology testing...

Ebola treatment centre in Sierra Leone to be run by UK health charity

Posted on: 24 November 2014 | Source: Doctors of the World UK

Doctors of the World UK is to run a 100-bed Ebola treatment centre in Sierra Leone that’s being custom-built in a town called Moyamba...

CHMP gives positive opinions of AbbVie’s VIEKIRAX™ and EXVIERA™

Posted on: 24 November 2014 | Source: Enanta Pharmaceuticals, Inc.

Enanta announces CHMP positive opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the treatment of chronic hepatitis C in Europe...